## Abstract Transforming growth factor (TGF)‐β1, whose gene is located on mouse chromosome 7, has been proposed to be involved in skin carcinogenesis. In the study presented here, we demonstrated that single topical treatments with different types of tumor promoters, i.e., the protein kinase C acti
Transforming growth factor-β1 expression in Syrian hamster cheek pouch carcinogenesis
✍ Scribed by Jean C. Zenklusen; Sharon L. Stockman; Susan M. Fischer; Claudio J. Conti; Irma B. Gimenez-Conti
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 603 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The expression pattern of transforming growth factor‐β1 (TGF‐β1) during the stages of complete carcinogenesis in the hamster cheek pouch model was studied. The right cheek pouches of 18 male hamsters were treated with 0.5% 7,12‐dimethylbenz[a]anthracene (DMBA) for 16 wk. TGF‐β1 was detected immunohistochemically in the resulting samples with two different polyclonal monospecific antibodies that recognize intracellular and extracellular forms of TGF‐β1. In the normal cheek pouch, extracellular protein stained the corium strongly, but the reaction was not evenly distributed. As treatment progressed, the reaction increased in both area and intensity; the peak was reached at 8 wk. Intracellular TGF‐β1 expression followed a similar pattern, with a peak at 4 wk of treatment. The results of northern blot analysis were concordant with the immunohistochemical results. Overexpression of TGF‐β1 was also observed in the malignant tumors, but only the extracellular form of the protein was present; intracellular TGF‐β1 was not detected in these tumors. The expression of TGF‐β1 in this carcinogenesis model seems to have two formal stages, the first being an overexpression step as a reaction to the uncontrolled growth and the second being one in which tumors have no internal expression of TGF‐β1 but in which external protein accumulates in the surrounding stroma. A possible explanation of this paradox may be that TGF‐β1 has functions other than its growth‐repressing activity. © 1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Transforming growth factor-Pl (TGF-Pl) is a potent growth inhibitor of epithelial cell growth, but can also stimulate stromal cell growth. Loss of responsiveness to TGF-/)l or loss of TGF-P1 itself may be important in the progression of cervical intraepithelial neoplasia (CIN) to invasive cervical c
Hepatocyte growth factor, a potent hepatocyte mitogen in vitro, appears to trigger hepatocyte regeneration after partial hepatectomy and after acute liver cell netcrosis. Transforming growth factor-a and transforming growth factor+, may also be involved in the control of liver regeneration. In this
## Abstract The __Nkx2.1__ homeobox gene and transforming growth factor‐β1 (TGF‐β1) are essential for organogenesis and differentiation of the mouse lung. NKX2.1 is a marker of human lung carcinomas, but it is not known whether this gene participates in early tumorigenesis. Addition of TGF‐β1 to TG
## Abstract Allergic asthma is characterized by airway hyperreactivity (AHR), eosinophilic airway inflammation and elevated serum IgE levels. T‐helper 2 (Th2) cells play a critical role in the pathogenesis of asthma, but the immunological mechanisms that inhibit Th2 cell function __in vivo__ are no
Transforming growth factor-/3 (TGFP) is a growth modulator that stimulates the growth of fibroblastic cells but inhibits the growth of cells of epithelial origin. TGFP also influences the production of extracellular matrix proteins, and of proteases and the type 1 plasminogen activator inhibitor (PA